A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy
about
Dysregulation of histone acetyltransferases and deacetylases in cardiovascular diseasesProtein kinase C-related kinase targets nuclear localization signals in a subset of class IIa histone deacetylasesStructural and functional analysis of the human HDAC4 catalytic domain reveals a regulatory structural zinc-binding domainHistone deacetylase signaling in cardioprotectionChemistry and biology of reactive oxygen species in signaling or stress responsesMitochondrial dysfunction in heart failureCysteine oxidative posttranslational modifications: emerging regulation in the cardiovascular systemNew insights into the role of mitochondrial dynamics and autophagy during oxidative stress and aging in the heartRedox modification of cell signaling in the cardiovascular systemThioredoxin/Txnip: redoxisome, as a redox switch for the pathogenesis of diseasesEpigenetics: a new mechanism of regulation of heart failure?Regulation of cell survival and death by pyridine nucleotidesIdentification of novel nuclear targets of human thioredoxin 1Structure of the N-terminal domain of human thioredoxin-interacting proteinThe role of sirtuins in cardiac diseaseRegulation of class IIa HDAC activities: it is not only matter of subcellular localizationPathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implicationsPost-translational modifications regulate class IIa histone deacetylase (HDAC) function in health and diseaseRedox-dependent disulfide bond formation in SAP30L corepressor protein: Implications for structure and functionModulation of chromatin position and gene expression by HDAC4 interaction with nucleoporinsSignal transduction by reactive oxygen speciesROSics: chemistry and proteomics of cysteine modifications in redox biology.Ubiquitin-dependent degradation of HDAC4, a new regulator of random cell motility.Redox regulation of cell survival by the thioredoxin superfamily: an implication of redox gene therapy in the heart.Muscle-specific RING finger 1 negatively regulates pathological cardiac hypertrophy through downregulation of calcineurin A.Intracellular shuttling and mitochondrial function of thioredoxin-interacting protein.Tetrandrine blocks cardiac hypertrophy by disrupting reactive oxygen species-dependent ERK1/2 signallingCardiac Cell Senescence and Redox Signaling.Characterization, design, and function of the mitochondrial proteome: from organs to organismsIFNgamma mediates DUOX2 expression via a STAT-independent signaling pathway.Disruption of chaperone-mediated autophagy-dependent degradation of MEF2A by oxidative stress-induced lysosome destabilization.Clinical and genetic correlates of circulating angiopoietin-2 and soluble Tie-2 in the community.HDAC4: mechanism of regulation and biological functionsDecreased SIRT2 activity leads to altered microtubule dynamics in oxidatively-stressed neuronal cells: implications for Parkinson's disease.PKA phosphorylates histone deacetylase 5 and prevents its nuclear export, leading to the inhibition of gene transcription and cardiomyocyte hypertrophy.NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart.Targeted quantitation of site-specific cysteine oxidation in endogenous proteins using a differential alkylation and multiple reaction monitoring mass spectrometry approachThioredoxin 1 negatively regulates angiotensin II-induced cardiac hypertrophy through upregulation of miR-98/let-7Elevated cytosolic Na+ increases mitochondrial formation of reactive oxygen species in failing cardiac myocytes.Epigenetic mechanisms in heart failure pathogenesis
P2860
39909cfec0b37fe2bc41a846c6fb90908a1c0c1f39ab23286c86c6c055f3a4fd37b84521425a844339b9d583c32e05e190acea315d5c8f611296fcd75765d5d4c0013f13899ad820d6b7d14dfdfb5bdc5d2388407127c0aa1794f1f5466e4bbab26919846d97ce804bc3538c049cfc1e1b223ac88b686f3387e518458c4aa239fe28c8a26816b7e1063ee2158aabb8f351171d996dfa6a9c64fa8f90bff2976c8ac31aafb1f7d104fd427c7e9671512078563e78cfb2288d151f97a067d915015b9994f8bfb089e0d4132fe302c9e71a1ea1917ac74caf15d42892c8e952964209e7c626fc1b30ada3998a98bd2dac4d
P248
Q21284678-41A4C693-D2E1-45CB-ABCE-694D54CCF0C4Q24301231-D06CF9D5-8D7A-48BE-B071-F2511486C027Q24311550-3CEF1E86-9069-4013-9827-71D4CF6D3F4FQ24568237-49AD20C2-00EF-4E0E-BB73-07D61FCEA6A6Q24633682-8DE3C21C-4CF7-4715-AC29-9AB4D05FAEEDQ26851293-D31D4912-4410-4D1B-BF80-E895D445D471Q26851695-DE99CC14-058E-41FD-B9F3-FB18F6483813Q26865574-619D5C74-B70D-4226-B1EE-3FE282557F25Q27000640-B4F7A00F-AAC6-4543-A6D5-E089C9C737FBQ27003070-D7779E4C-155E-41BA-82EE-903C29247E8FQ27013611-2F434AF8-5E84-48FA-8C28-1447D17353AFQ27026075-AAB8C0F6-9122-4053-9081-38B6D15E5BD3Q27311872-0522BE37-3B2B-4900-B59F-F698A4A92B60Q27684226-8AFAA5DB-4DE7-4E24-8788-1353DBD897B4Q27693274-EE0432A6-AAF3-4E68-8FAE-7E0E63C4186AQ28077331-72BA17CF-3ACF-4F92-8A1E-6959A1111572Q28085102-38665D08-38B3-4094-AE77-51F590203D8EQ28088517-4181CA94-1F22-4B7A-9993-2ED54243840DQ28114970-6EC2D07F-D16E-4986-8300-C865B2334F05Q28572931-3853F18F-212B-49A3-9521-8E0D6F500413Q29615230-37AC33C3-B6DA-4A17-9F7D-172FDDE91668Q30363450-94966C9F-5478-491E-960C-E9348BA409BDQ30497896-A3F9A11D-5F66-42FF-B849-20F7157D14A2Q33649846-93D6ADE5-1AC6-491E-8882-B13D6EF3FF47Q33651036-2569CDEA-5DD7-4EE0-BED1-DF5D758236CEQ33662243-B8F07554-27AB-463D-86B6-EC98954625C3Q33690802-982E3839-C861-4EE7-8FFD-5A225FD88912Q33734782-03F52145-04DA-400E-83EC-6ED3A6A20ABCQ33826618-3844221D-461D-4E54-A7F5-FE38E8A244ADQ33844913-3A6165CF-33F2-4008-BAAF-E06A1F1DCE6CQ33878919-F481DD8F-4868-4841-B46D-FCF49F784BE5Q33944299-7B466CCD-6755-49BA-9F36-5274C8AB33F8Q34039987-BF7259B4-2768-4A14-B8F8-B5CD9E4DB8EAQ34077953-C7ADA9ED-0058-424C-9F23-EC018FA91778Q34100575-C6103FE7-1587-47C1-9027-E9021065DC0EQ34100612-680E674E-1469-4BEC-A1FD-FDB5F863755DQ34122054-C535ABBF-5FA9-4B11-B48F-48084CBCBF6BQ34156481-06142B8E-9BF8-4F25-9259-39B9449D2D79Q34157229-1F1ACBE9-9B89-4999-BBB7-719143759FEDQ34212728-0004C287-A123-48ED-9657-FF8F70887B12
P2860
A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy
description
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2008
@ast
im Juni 2008 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2008/06/13)
@sk
vědecký článek publikovaný v roce 2008
@cs
wetenschappelijk artikel (gepubliceerd op 2008/06/13)
@nl
наукова стаття, опублікована в червні 2008
@uk
مقالة علمية (نشرت في 13-6-2008)
@ar
name
A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy
@ast
A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy
@en
A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy
@nl
type
label
A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy
@ast
A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy
@en
A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy
@nl
prefLabel
A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy
@ast
A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy
@en
A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy
@nl
P2093
P921
P1433
P1476
A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy
@en
P2093
Jeffery D. Molkentin
Peiyong Zhai
Stephen F. Vatner
Tetsuro Ago
P304
P356
10.1016/J.CELL.2008.04.041
P407
P577
2008-06-13T00:00:00Z